These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 35004679)

  • 1. Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets.
    Chen DH; Zhang JG; Wu CX; Li Q
    Front Cell Dev Biol; 2021; 9():778582. PubMed ID: 35004679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
    Qin S; Mao Y; Wang H; Duan Y; Zhao L
    Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment.
    Si C; Chen C; Guo Y; Kang Q; Sun Z
    Front Cell Dev Biol; 2021; 9():711815. PubMed ID: 34660577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenine modification in noncoding RNAs and its function in cancer.
    Yang X; Hu X; Liu J; Wang R; Zhang C; Han F; Chen Y; Ma D
    Biomark Res; 2020 Nov; 8(1):61. PubMed ID: 33292652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
    Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
    Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
    Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
    Front Oncol; 2022; 12():927640. PubMed ID: 35936737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer.
    Luo L; Zhen Y; Peng D; Wei C; Zhang X; Liu X; Han L; Zhang Z
    Cell Death Discov; 2022 Jul; 8(1):325. PubMed ID: 35851061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types.
    Shen S; Zhang R; Jiang Y; Li Y; Lin L; Liu Z; Zhao Y; Shen H; Hu Z; Wei Y; Chen F
    Mol Cancer; 2021 Apr; 20(1):67. PubMed ID: 33849552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
    Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
    Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m6A Modification: A Double-Edged Sword in Tumor Development.
    Gao R; Ye M; Liu B; Wei M; Ma D; Dong K
    Front Oncol; 2021; 11():679367. PubMed ID: 34381710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Link Between m6A Modification and Cancers.
    Liu ZX; Li LM; Sun HL; Liu SM
    Front Bioeng Biotechnol; 2018; 6():89. PubMed ID: 30062093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA.
    Zhang Z; Wei W; Wang H; Dong J
    Front Oncol; 2021; 11():743990. PubMed ID: 34722298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m6A modification in RNA: biogenesis, functions and roles in gliomas.
    Zhang Y; Geng X; Li Q; Xu J; Tan Y; Xiao M; Song J; Liu F; Fang C; Wang H
    J Exp Clin Cancer Res; 2020 Sep; 39(1):192. PubMed ID: 32943100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
    Chen M; Wong CM
    Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
    Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
    Front Oncol; 2021; 11():635329. PubMed ID: 33928028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functions of N6-methyladenosine modification in lncRNAs.
    He RZ; Jiang J; Luo DX
    Genes Dis; 2020 Dec; 7(4):598-605. PubMed ID: 33335959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate.
    Xu Y; Liu J; Chen WJ; Ye QQ; Chen WT; Li CL; Wu HT
    Front Cell Dev Biol; 2020; 8():561703. PubMed ID: 33072746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.